{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "The invention concerns pyrimidine derivatives of Formula (I) wherein each of p, R<SUP>1</SUP>, R<SUP>2</SUP>, q, R<SUP>3</SUP>, r, R<SUP>4</SUP>, X<SUP>1 </SUP>and Q<SUP>1 </SUP>have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E400570-T1: [Translated] 2,4,6-TRISUBSUTITUTED PYRIMIDINES AS INHIBITORS OF PHOSPHATIDYLINOSITE (PI)3-KINASE AND THEIR USE IN THE TREATMENT OF CANCER on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400570-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/544p-eqpg", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/544p-eqpg", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E400570-T1: [Translated] 2,4,6-TRISUBSUTITUTED PYRIMIDINES AS INHIBITORS OF PHOSPHATIDYLINOSITE (PI)3-KINASE AND THEIR USE IN THE TREATMENT OF CANCER"}